Investigating the Effect of Cervical Spondylotic Myelopathy on Patients’ Handwriting

Overview

About this study

The purpose of this study is to determine if there are any changes in handwriting of patients with cervical spondylotic myelopathy, and assess the value of handwriting changes as an early predictor in the disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Confirmed cervical spondylotic myelopathy (CSM) diagnosis
CSM patients undergoing surgical treatment
Patients above the age of 21

Exclusion Criteria:

Patients under the age of 21
Patients with upper extremity deformities
Patients with any neurological impairments or diseases that could confound variables

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Mohamad Bydon, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Bydon, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials